Cargando…
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study
Thrombosis remains an important complication for children with single‐ventricle physiology following the Fontan procedure, and effective thromboprophylaxis is an important unmet medical need. To obviate conventional dose‐finding studies and expedite clinical development, a rivaroxaban dose regimen f...
Autores principales: | Zhu, Peijuan, Willmann, Stefan, Zhou, Wangda, Yang, Haitao, Michelson, Alan D., McCrindle, Brian W., Li, Jennifer S., Harris, Kevin C., Pina, Liza Miriam, Weber, Traci, Nessel, Kimberly, Lesko, Lawrence J., Kubitza, Dagmar, Zannikos, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303933/ https://www.ncbi.nlm.nih.gov/pubmed/34524700 http://dx.doi.org/10.1002/jcph.1966 |
Ejemplares similares
-
Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease
por: Willmann, Stefan, et al.
Publicado: (2022) -
Thromboprophylaxis for Children Post‐Fontan Procedure: Insights From the UNIVERSE Study
por: McCrindle, Brian W., et al.
Publicado: (2021) -
Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions
por: Willmann, Stefan, et al.
Publicado: (2021) -
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications
por: Kubitza, Dagmar, et al.
Publicado: (2016) -
Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations
por: Willmann, Stefan, et al.
Publicado: (2018)